LivaNova Plc
(NASDAQ : LIVN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 7.74%25.196.3%$1412.94m
TMOThermo Fisher Scientific, Inc. 1.78%389.391.0%$565.50m
MDTMedtronic Plc 2.70%93.260.6%$537.33m
DXCMDexCom, Inc. -0.34%438.168.2%$523.94m
ABTAbbott Laboratories 2.45%95.320.8%$507.03m
BDXBecton, Dickinson & Co. 1.53%261.311.0%$503.04m
DHRDanaher Corp. 1.06%185.610.7%$451.32m
BSXBoston Scientific Corp. 0.72%34.931.0%$432.54m
QDELQuidel Corp. 2.06%251.737.7%$420.62m
ISRGIntuitive Surgical, Inc. 1.90%586.832.4%$340.31m
SYKStryker Corp. 1.17%179.971.3%$312.15m
BAXBaxter International, Inc. -0.25%85.021.8%$274.95m
ALGNAlign Technology, Inc. 1.53%277.486.4%$227.72m
ZBHZimmer Biomet Holdings, Inc. 2.34%122.221.7%$210.09m
BIOBio-Rad Laboratories, Inc. 1.26%483.672.9%$201.59m

Company Profile

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.